Capilar Test

This is a test that enables the assessment of genetic risk of androgenic alopecia

The objective of the Capillary Test is to evaluate the risk of developing androgenic alopecia (common baldness), before the onset of symptoms, enabling the diagnosis in earlier or preclinical stage, so treatment can be started at a time when it has a higher probability of success.

The current diagnosis of alopecia is based on visual observation of the decrease in the thickness and amount of hair. When this is already visible, it is likely that around 50% of the hair is already lost in that area. This is because the only drugs currently used to fight hair loss, Minoxidil and Finasteride, are more effective in stabilizing the fall of hair rather than the generation of new hair. That is why the sooner the probability of presenting alopecia can be predicted, the more chances you have to save your hair.

The Capillary Test helps you evaluate the risk of hair loss and offers the opportunity for early medical intervention before the appearance of visible signs of loss.

For more information and questions contact us.